IRTC - IRHYTHM INVESTOR ALERT: Kirby McInerney LLP Notifies iRhythm Technologies Inc. (IRTC) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit | Benzinga

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the April 8, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired iRhythm Technologies, Inc. ("iRhythm" or the "Company) (NASDAQ:IRTC) securities during the period from January 11, 2022 through May 30, 2023, inclusive. Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

[Click here to learn more about the class action]

On November 1, 2022, iRhythm revised fourth quarter and full-year guidance, explaining during a conference call that it voluntarily issued a Customer Advisory Notice to its Zio AT customers. Consequently, the Company reduced its Zio AT forecast for the quarter from the 40% growth target it had provided throughout the past three quarters to 20%. On this news, the price of iRhythm shares declined by $14.07 per share, or approximately 11.6%, from $121.17 per share on November 2, 2022 to close at $107.10 on November 3, 2022.

On November 4, 2022, the Company disclosed that it initiated the Customer Advisory Notice on September 28, 2022, following issues raised by the FDA during an inspection that culminated in an inspection observation report on Form 483, and that the Customer Advisory Notice warned patients of a labeling correction related to ...

IRTC) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit>Full story available on Benzinga.com